Expression profiling of CIP4 in primary tumors from 245 patients with invasive breast carcinoma, has also revealed high CIP4 levels in TNBC and HER2 subtypes, and risk of progression to metastatic disease. The gene discussed is ERBB2; the disease is metastatic neoplasm.